Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation

Reduced Intensity

326 Pre-transplant serum ferritin and marrow donor CD34+-cell-chimerism day 28 correlate with outcome after allogeneic hematopoietic transplantation following reduced-intensity-conditioning in MDS

Leukemia Research ◽

10.1016/s0145-2126(11)70328-9 ◽

2011 ◽

Vol 35 ◽

pp. S130-S131

Author(s):

H. Al-Ali ◽

N. Jaekel ◽

C. Nehring ◽

K. Rainer ◽

C. Becker ◽

...

Keyword(s):

Serum Ferritin ◽

Reduced Intensity Conditioning ◽

Reduced Intensity

REDUCED-INTENSITY CONDITIONING USING ALEMTUZUMAB IN ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION.

Journal of Investigative Medicine ◽

10.1097/00042871-200701010-00734 ◽

2007 ◽

Vol 55 (1) ◽

pp. S283

Author(s):

S. Arledge ◽

S. Elkins ◽

C. Bigelow ◽

J. Files ◽

V. Herrin ◽

...

Keyword(s):

Reduced Intensity Conditioning ◽

Reduced Intensity

Reduced-Intensity Allogeneic Hematopoietic Transplantation Should Be Considered a Standard of Care for Older Patients with Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2011.10.009 ◽

2011 ◽

Vol 17 (12) ◽

pp. 1723-1724 ◽

Cited By ~ 7

Author(s):

Richard Champlin

Keyword(s):

Acute Myeloid Leukemia ◽

Older Patients ◽

Myeloid Leukemia ◽

Standard Of Care ◽

Reduced Intensity ◽

Acute Myeloid

Reduced intensity allogeneic hematopoietic transplantation is an established standard of care for treatment of older patients with acute myeloid leukemia

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2013.10.011 ◽

2013 ◽

Vol 26 (3) ◽

pp. 297-300 ◽

Cited By ~ 14

Author(s):

Richard Champlin

Keyword(s):

Acute Myeloid Leukemia ◽

Older Patients ◽

Myeloid Leukemia ◽

Standard Of Care ◽

Reduced Intensity ◽

Acute Myeloid

Phase II Study of Mega-Dose 90Y-Ibritumomab Tiuxetan, Fludarabine and Low-Dose TBI Followed By Allogeneic Hematopoietic Transplantation for Relapsed or Refractory Aggressive Large B-Cell Lymphoma: Long-Term Outcomes

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00510-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S395-S396

Author(s):

Victor A. Chow ◽

Ryan D. Cassaday ◽

Ted A. Gooley ◽

Brenda M. Sandmaier ◽

Stephen D. Smith ◽

...

Keyword(s):

Low Dose ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Long Term Outcomes ◽

Ibritumomab Tiuxetan ◽

Large B Cell Lymphoma ◽

Infliximab for the Treatment of Severe Steroid Refractory Acute Graft-versus-host Disease in Three Patients after Allogeneic Hematopoietic Transplantation

Leukemia & Lymphoma ◽

10.1080/1042819031000123483 ◽

2003 ◽

Vol 44 (12) ◽

pp. 2095-2097 ◽

Cited By ~ 24

Author(s):

Takahisa Yamane ◽

Ryousuke Yamamura ◽

Yasutaka Aoyama ◽

Hirohisa Nakamae ◽

Taro Hasegawa ◽

...

Keyword(s):

Graft Versus Host Disease ◽

Host Disease ◽

Graft Versus Host ◽

Steroid Refractory ◽

Acute Graft

Donation Activities and Product Integrity in Unrelated Donor Allogeneic Hematopoietic Transplantation: Experience of the National Marrow Donor Program

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.06.001 ◽

2008 ◽

Vol 14 (9) ◽

pp. 23-28 ◽

Cited By ~ 12

Author(s):

Charles D. Bolan ◽

Robert J. Hartzman ◽

Elizabeth H. Perry ◽

Lance Trainor ◽

John Miller ◽

...

Keyword(s):

Unrelated Donor ◽

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups

Bone Marrow Transplantation ◽

10.1038/s41409-021-01252-7 ◽

2021 ◽

Author(s):

Marie Robin ◽

Raphael Porcher ◽

Corentin Orvain ◽

Jacques-Olivier Bay ◽

Fiorenza Barraco ◽

...

Keyword(s):

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

Current Opinion in Immunology ◽

10.1016/j.coi.2009.07.015 ◽

2009 ◽

Vol 21 (5) ◽

pp. 525-530 ◽

Cited By ~ 93

Author(s):

Andrea Velardi ◽

Loredana Ruggeri ◽

Antonella Mancusi ◽

Franco Aversa ◽

Frank T Christiansen

Keyword(s):

Natural Killer Cell ◽

Natural Killer ◽

Killer Cell ◽

Missing Self ◽

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria

Haematologica ◽

10.3324/haematol.2018.198549 ◽

2019 ◽

Vol 104 (8) ◽

pp. 1682-1688 ◽

Cited By ~ 36

Author(s):

Giorgia Battipaglia ◽

Florent Malard ◽

Marie Therèse Rubio ◽

Annalisa Ruggeri ◽

Anne Claire Mamez ◽

...

Keyword(s):

Multidrug Resistance ◽

Fecal Microbiota Transplantation ◽

Hematologic Malignancies ◽

Fecal Microbiota ◽